Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Russell Y Cruz

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Molecular Therapy. Oncology|October 11, 2024
Bridging the antigen-presentation gap for adoptive cell therapiesAmy B Hont, C Russell Y Cruz
Cytotherapy|October 1, 2016
EditorialC Russell Y Cruz, Michael Andreeff, John Barrett
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2019
Engineering the TGFβ Receptor to Enhance the Therapeutic Potential of Natural Killer Cells as an Immunotherapy for NeuroblastomaRachel A Burga, Eric Yvon, Elizabeth Chorvinsky, et al.
Nano Research|June 3, 2021
PLGA nanodepots co-encapsulating prostratin and anti-CD25 enhance primary natural killer cell antiviral and antitumor functionElizabeth E Sweeney, Preethi B Balakrishnan, Allison B Powell, et al.
Cytotherapy|June 6, 2023
Engineered tumor-specific T cells using immunostimulatory photothermal nanoparticlesElizabeth E Sweeney, Palak Sekhri, Deepti Telaraja, et al.
Research Square|June 10, 2024
Limited Immunogenicity of an HLA-A*03:01-restricted Epitope of Erv-k-env in Non-hiv-1 Settings: Implications for Adoptive Cell Therapy in CancerErin E Grundy, Lauren C Shaw, Loretta Wang, et al.
Blood Advances|September 18, 2025
Risk biomarkers of chronic GVHD in children aged 10 years or younger and children/adults older than 10 yearsAnna C Ferreira, Debjani Dutta, Courtney M Rowan, et al.
Mobile DNA|October 10, 2024
A T cell receptor specific for an HLA-A*03:01-restricted epitope in the endogenous retrovirus ERV-K-Env exhibits limited recognition of its cognate epitopeErin E Grundy, Lauren C Shaw, Loretta Wang, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
A pan-cancer atlas of therapeutic T cell targetsGuangyuan Li, Omar U Guzmán-Bringas, Aman Sharma, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Therapy. Oncology|October 11, 2024
Bridging the antigen-presentation gap for adoptive cell therapiesAmy B Hont, C Russell Y Cruz
Cytotherapy|October 1, 2016
EditorialC Russell Y Cruz, Michael Andreeff, John Barrett
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2019
Engineering the TGFβ Receptor to Enhance the Therapeutic Potential of Natural Killer Cells as an Immunotherapy for NeuroblastomaRachel A Burga, Eric Yvon, Elizabeth Chorvinsky, et al.
Nano Research|June 3, 2021
PLGA nanodepots co-encapsulating prostratin and anti-CD25 enhance primary natural killer cell antiviral and antitumor functionElizabeth E Sweeney, Preethi B Balakrishnan, Allison B Powell, et al.
Cytotherapy|June 6, 2023
Engineered tumor-specific T cells using immunostimulatory photothermal nanoparticlesElizabeth E Sweeney, Palak Sekhri, Deepti Telaraja, et al.
Research Square|June 10, 2024
Limited Immunogenicity of an HLA-A*03:01-restricted Epitope of Erv-k-env in Non-hiv-1 Settings: Implications for Adoptive Cell Therapy in CancerErin E Grundy, Lauren C Shaw, Loretta Wang, et al.
Blood Advances|September 18, 2025
Risk biomarkers of chronic GVHD in children aged 10 years or younger and children/adults older than 10 yearsAnna C Ferreira, Debjani Dutta, Courtney M Rowan, et al.
Mobile DNA|October 10, 2024
A T cell receptor specific for an HLA-A*03:01-restricted epitope in the endogenous retrovirus ERV-K-Env exhibits limited recognition of its cognate epitopeErin E Grundy, Lauren C Shaw, Loretta Wang, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
A pan-cancer atlas of therapeutic T cell targetsGuangyuan Li, Omar U Guzmán-Bringas, Aman Sharma, et al.
Pageof 1